Reporter Jan 13 2023

Federally funded studies into treatment for chronic conditions overlook efficacy in adults with autism, analysis finds

Jan. 13, 2023—Physical health disparity conditions in autistic adults have not been the focus of any research funded by the U.S. National Institutes of Health (NIH) in the last four decades, an analysis of a federal database found.

Dominic Gamez is resuming more activities since he received an expandable prosthesis to treat osteosarcoma in his left leg.

Expandable prosthesis gives young patient more mobility

Jan. 12, 2023—To treat the osteosarcoma in his left leg, Dominic Gamez, 7, and his family chose to have a magnetic expandable prosthesis implanted that can be manipulated to grow incrementally as the child grows.

Antibody “fingerprinting” method potential advance to slow spread of dengue

Jan. 12, 2023—Vanderbilt researchers have reported a major advance in understanding and potentially preventing dengue, a devastating, mosquito-borne tropical viral infection that is spreading across the globe.

Alexander Bick, MD, PhD, and colleagues are studying inflammation at the single-cell level in the rare disease RUNX1-FPD.

Chan Zuckerberg Initiative grant supports single-cell study of rare inherited disease

Jan. 12, 2023—A multidisciplinary team led by Vanderbilt University Medical Center investigator Alexander Bick, MD, PhD, has been awarded a $2 million, four-year grant to study inflammation at the single-cell level in the rare disease RUNX1-FPD.

Vanderbilt Nursing and Department of Pharmaceutical Services personnel worked together to create the Medication Safety Champions program, intended to improve medication safety throughout Vanderbilt University Hospital.

Program at VUH seeks to improve medication safety

Jan. 12, 2023—Vanderbilt Nursing and the Department of Pharmaceutical Services have teamed up to create the Medication Safety Champions program, intended to improve medication safety throughout Vanderbilt University Hospital.

Study may lead to new diabetes, heart disease treatments

Jan. 12, 2023—Vanderbilt research found that deletion of an autophagy-participating factor named PIK3C3 from the fat cells of mice led to compromised body temperature control, abnormal blood lipid levels, fatty liver and diabetes.

Clinical trial compares different therapies for spine pain

Jan. 12, 2023—A Vanderbilt clinical trial to determine whether multidisciplinary biopsychosocial intervention or individualized postural therapy intervention improved disability and reduced health care spending in patients with acute or subacute spine pain.